Literature DB >> 29468602

Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.

Ed Whalen1, Manfred Hauben2,3, Andrew Bate2.   

Abstract

INTRODUCTION: Signal detection remains a cornerstone activity of pharmacovigilance. Routine quantitative signal detection primarily focuses on screening of spontaneous reports. In striving to enhance quantitative signal detection capability further, other data streams are being considered for their potential contribution as sources of emerging signals, one of which is longitudinal observational databases, including electronic medical record (EMR) and transactional insurance claims databases. Quantitative signal detection on such databases is a nascent field-with published methods being primarily based either on individual metrics, which may not effectively represent the complexity of the longitudinal records and their necessary variation for analysis for drug-outcome pairs, or on visualization discovery approaches leveraging multiple aspects of the records, which are not particularly tractable to high-throughput hypothesis-free signal detection. One extensively tested example of the latter is chronographs.
METHODS: We apply a disturbance detection algorithm to chronographs using UK EMR The Health Improvement Network (THIN) data. The algorithm utilizes autoregressive integrated moving average (ARIMA)-based time series methodology designed to find disturbances that occur outside the normal pattern trends of the ARIMA model for the chronograph. Chronographs currently highlight drug-event pairs as potentially worthy of further clinical assessment, via filter-based increases in disproportionality scores from before to after the index drug exposure, tested across a range of case and control windows.
RESULTS: We replicate the findings on six exemplar chronographs from a previous publication, and show how disturbances can be effectively detected across this set of pairs. Further, 692 disturbances were detected in analysis of all 384 individual READ code outcomes ever recorded 50 or more times for patients prescribed sibutramine. The disturbances are algorithmically further broken into subsets of clinical interest.
CONCLUSION: Overall, the disturbance algorithm approach shows promising capacity for detecting outliers, and shows tractability of the algorithmic approach for large-scale screening. The method offers an array of pattern types for detection and clinical review.

Entities:  

Mesh:

Year:  2018        PMID: 29468602     DOI: 10.1007/s40264-018-0640-8

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  15 in total

1.  Terminological challenges in safety surveillance.

Authors:  Andrew Bate; Elliot G Brown; Stephen A Goldman; Manfred Hauben
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database.

Authors:  Izyan A Wahab; Nicole L Pratt; Lisa Kalisch Ellett; Elizabeth E Roughead
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

3.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

Review 4.  Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.

Authors:  Vaishali K Patadia; Preciosa Coloma; Martijn J Schuemie; Ron Herings; Rosa Gini; Giampiero Mazzaglia; Gino Picelli; Carla Fornari; Lars Pedersen; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Expert Rev Clin Pharmacol       Date:  2015-01       Impact factor: 5.045

Review 5.  Methods for safety signal detection in healthcare databases: a literature review.

Authors:  Mickael Arnaud; Bernard Bégaud; Nicolas Thurin; Nicholas Moore; Antoine Pariente; Francesco Salvo
Journal:  Expert Opin Drug Saf       Date:  2017-05-15       Impact factor: 4.250

6.  Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.

Authors:  James D Lewis; Rita Schinnar; Warren B Bilker; Xingmei Wang; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-04       Impact factor: 2.890

7.  Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates.

Authors:  Betina T Blak; Mary Thompson; Hassy Dattani; Alison Bourke
Journal:  Inform Prim Care       Date:  2011

8.  EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.

Authors:  Gianluca Trifirò; Vaishali Patadia; Martijn J Schuemie; Preciosa M Coloma; Rosa Gini; Ron Herings; Julia Hippisley-Cox; Giampiero Mazzaglia; Carlo Giaquinto; Lorenza Scotti; Lars Pedersen; Paul Avillach; Miriam C J M Sturkenboom; Johan van der Lei
Journal:  Stud Health Technol Inform       Date:  2011

9.  Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.

Authors:  G Niklas Norén; Tomas Bergvall; Patrick B Ryan; Kristina Juhlin; Martijn J Schuemie; David Madigan
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

10.  Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.

Authors:  S Cederholm; G Hill; A Asiimwe; A Bate; F Bhayat; G Persson Brobert; T Bergvall; D Ansell; K Star; G N Norén
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

View more
  5 in total

Review 1.  Machine Learning in Causal Inference: Application in Pharmacovigilance.

Authors:  Yiqing Zhao; Yue Yu; Hanyin Wang; Yikuan Li; Yu Deng; Guoqian Jiang; Yuan Luo
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

2.  Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 'Futures' Edition".

Authors:  Manfred Hauben; William W Gregory; Patrick Caubel
Journal:  Clin Pharmacol Ther       Date:  2020-03-20       Impact factor: 6.875

3.  Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.

Authors:  Andrew Bate; Ken Hornbuckle; Juhaeri Juhaeri; Stephen P Motsko; Robert F Reynolds
Journal:  Ther Adv Drug Saf       Date:  2019-08-05

4.  Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data.

Authors:  Odile Sauzet; Victoria Cornelius
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

5.  Artificial Intelligence, Real-World Automation and the Safety of Medicines.

Authors:  Andrew Bate; Steve F Hobbiger
Journal:  Drug Saf       Date:  2020-10-07       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.